Interestingly, the subgroup of KRAS‐mutated tumor with coexisting amplifications of the KRAS‐mutated allele is characterized by marked rewiring of glucose metabolism toward glutathione biosynthesis, mirroring the CMS3 metabolic adaptation seen in CRC 61. Here, KRAS is linked to colorectal carcinoma.